- Motley Fool•35 minutes ago
Could the billionaire's reported investment mean something big is about to happen for Bristol-Myers Squibb?
- TheStreet.com•2 days ago
You have to keep up with the sector rotations.
- Zacks•2 days ago
Cancer drugs developed by Pfizer (PFE) and Novartis got priority review while Bristol-Myers is being considered the next acquisition target.
BMY : Summary for Bristol-Myers Squibb Company - Yahoo Finance
Bristol-Myers Squibb Company (BMY)
NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
|Day's Range||55.88 - 56.47|
|52 Week Range||46.01 - 77.12|
Trade prices are not sourced from all markets
|PE Ratio (TTM)||21.30|
|Dividend & Yield||1.56 (2.76%)|
|1y Target Est||N/A|